Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
UTI - Unit Linked Insurance Plan
★★★★★ 3rd-party
External rating
- Source: Third-party data provider (Groww/CRISIL)
- Original rating: 4/5, displayed as-is — TopFund does not modify third-party ratings
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria
TopFund Score: 77/100 · Good
How this score is calculated
- Star rating (35%)4/5
- 3Y CAGR (30%)7.53%
- Expense ratio (20%)0.25%
- AUM (15%)₹17,423 Cr
Not investment advice — an analytical read of public fund data. Methodology →
UTI Mutual Fund · Hybrid · Dynamic Asset Allocation or Balanced Advantage
₹43.53
AUM: ₹17,422 Cr
NAV updated 3 days ago
Plan
Direct
Option
Growth
Risk
High
Expense Ratio
0.25%
Exit Load
Exit load of 1% if redeemed within 15 days.
Fund Manager
Raviprakash Sharma
Inception
Jan 2013
Benchmark
Domestic Price of Gold
Sharpe Ratio
-0.67
Std Dev (1Y)
6.64%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+2.94%
3m
-0.18%
6m
+6.98%
1y
+2.35%
3y
+7.53%
5y
+5.27%
10y
+7.5%
since inception
+5.22%
TopFund's Take on UTI - Unit Linked Insurance Plan
UTI - Unit Linked Insurance Plan holds up reasonably well within the Dynamic Asset Allocation or Balanced Advantage category, backed by a 4-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 77/100.
Cost: At 0.25%, the expense ratio is meaningfully cheaper — about 66% below the Dynamic Asset Allocation or Balanced Advantage category average of 0.73% (based on 4 comparable funds). Lower costs compound in your favour over long holding periods.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.67 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 6.64% is on the lower side for a Dynamic Asset Allocation or Balanced Advantage fund, suggesting a comparatively smoother ride.
Who should invest: This fund is best suited to investors who want a single fund blending equity growth with debt-driven stability. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Tools & Guides for This Fund
Frequently Asked Questions about UTI - Unit Linked Insurance Plan
The current NAV (Net Asset Value) of UTI - Unit Linked Insurance Plan is ₹43.53. NAV is updated every business day after market close by AMFI.
1Y: 2.35% · 3Y CAGR: 7.53% · 5Y CAGR: 5.27%
The expense ratio of UTI - Unit Linked Insurance Plan is 0.25% per annum. This is the annual fee charged by the fund to manage your investment.
UTI - Unit Linked Insurance Plan is managed by Raviprakash Sharma at UTI Mutual Fund.
UTI - Unit Linked Insurance Plan is classified as a High risk fund. It is suitable for investors with a long-term horizon of 3+ years.
UTI - Unit Linked Insurance Plan is a Dynamic Asset Allocation or Balanced Advantage fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in UTI - Unit Linked Insurance Plan with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of UTI - Unit Linked Insurance Plan is ₹17,423 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.